ImmunityBio (IBRX) Shareholder's Equity Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.80% |
| Dec 31, 2025 | -3.62% |
| Sep 30, 2025 | -6.85% |
| Jun 30, 2025 | -10.53% |
| Mar 31, 2025 | -20.49% |
| Dec 31, 2024 | -26.02% |
| Sep 30, 2024 | -57.65% |
| Jun 30, 2024 | -63.83% |
| Mar 31, 2024 | -55.06% |
| Dec 31, 2023 | -70.37% |
| Sep 30, 2023 | -100.34% |
| Jun 30, 2023 | -260.55% |
| Mar 31, 2023 | -195.07% |
| Dec 31, 2022 | -209.17% |
| Sep 30, 2022 | -72.76% |
| Jun 30, 2022 | -68.56% |
| Mar 31, 2022 | -58.89% |
| Dec 31, 2021 | -70.73% |
| Sep 30, 2021 | -46.93% |
| Jun 30, 2021 | -42.16% |
| Mar 31, 2021 | -43.01% |
| Dec 31, 2020 | -36.47% |
| Sep 30, 2020 | -30.35% |
| Jun 30, 2020 | -61.55% |
| Mar 31, 2020 | -27.53% |
| Dec 31, 2019 | -61.82% |
| Sep 30, 2019 | -24.10% |
| Jun 30, 2019 | -22.69% |
| Mar 31, 2019 | -21.32% |
| Dec 31, 2018 | -38.71% |
| Sep 30, 2018 | -23.51% |
| Jun 30, 2018 | 12.81% |
| Dec 31, 2017 | 56.05% |
| Dec 31, 2016 | 331.14% |